Teresa
Lozano Moreda
Profesional Investigadora
![Foto de Teresa](/img/nophoto.png)
![Foto de Hospital Universitario Central de Asturias](/img/noimage_org.png)
Hospital Universitario Central de Asturias
Oviedo, EspañaHospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3